In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?
2008
Does the Size of an Individual Trial Still Matter?
publication
Evidence: moderate
Author Information
Author(s): Gordon H. Guyatt, Edward J. Mills, Diana Elbourne
Primary Institution: McMaster University
Hypothesis
Does the sample size calculation for an individual trial still matter in the era of systematic reviews?
Conclusion
Individual trials, even large ones, rarely provide definitive answers, and systematic reviews are necessary for robust conclusions.
Supporting Evidence
- Systematic reviews are now considered the top of the hierarchy of clinical evidence.
- Small trials can be misleading and may not provide definitive answers.
- Funding for large trials is often limited and primarily from industry sources.
- Many potential trials are abandoned due to unrealistic sample size requirements.
- Peer-reviewed granting agencies should ask more appropriate questions regarding trial importance.
Takeaway
This study says that just because a trial is big doesn't mean it will give clear answers, and we need to look at many trials together to really understand things.
Potential Biases
Small trials may mislead due to selection bias and may stifle further investigation.
Limitations
The reliance on sample size calculations may lead to the abandonment of potentially valuable trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website